Literature DB >> 9039785

Complement and the immune response.

M C Carroll1, M B Fischer.   

Abstract

This past year has seen a major advance in our understanding of how the complement system enhances the adaptive immune response. The use of in vivo models has revealed that direct coupling of C3d to antigen is sufficient to dramatically reduce the amount of antigen required for a secondary response. At least one important requirement for the enhancing effect was determined to be expression of the CD21 (C3d receptor) on B cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039785     DOI: 10.1016/s0952-7915(97)80160-4

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  17 in total

1.  Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis.

Authors:  R F Guo; M Huber-Lang; X Wang; V Sarma; V A Padgaonkar; R A Craig; N C Riedemann; S D McClintock; T Hlaing; M M Shi; P A Ward
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Complement: an overview for the clinician.

Authors:  Juan Carlos Varela; Stephen Tomlinson
Journal:  Hematol Oncol Clin North Am       Date:  2015-04-04       Impact factor: 3.722

3.  Inhibition of C5a receptor alleviates experimental CNS lupus.

Authors:  Alexander Jacob; Bradley Hack; Tao Bai; James R Brorson; Richard J Quigg; Jessy J Alexander
Journal:  J Neuroimmunol       Date:  2010-03-05       Impact factor: 3.478

4.  Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.

Authors:  E N Tsitsikov; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury.

Authors:  Daniel E Cramer; Daniel J Allendorf; Jarek T Baran; Richard Hansen; Jose Marroquin; Bing Li; Janina Ratajczak; Mariusz Z Ratajczak; Jun Yan
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

6.  C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB.

Authors:  Alexander Jacob; Bradley Hack; Peili Chen; Richard J Quigg; Jessy J Alexander
Journal:  J Neurochem       Date:  2011-10-20       Impact factor: 5.372

7.  Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells.

Authors:  Srinivas Mamidi; Simon Höne; Claudia Teufel; Leopold Sellner; Thorsten Zenz; Michael Kirschfink
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

8.  Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

Authors:  Isaac M Chiu; Hemali Phatnani; Michael Kuligowski; Juan C Tapia; Monica A Carrasco; Ming Zhang; Tom Maniatis; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

9.  C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection.

Authors:  Yumi Nakayama; Shin-Il Kim; Eui Ho Kim; John D Lambris; Matyas Sandor; M Suresh
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

10.  C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus.

Authors:  Supriya D Mahajan; Neil U Parikh; Trent M Woodruff; James N Jarvis; Molly Lopez; Teresa Hennon; Patrick Cunningham; Richard J Quigg; Stanley A Schwartz; Jessy J Alexander
Journal:  Immunology       Date:  2015-07-15       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.